title: Molecular constituents of maxi KCa channels in human coronary smooth muscle: predominant alpha + beta subunit complexes.
abstract: 1. Human large-conductance voltage- and calcium-sensitive K+ (maxi KCa) channels are composed of at least two subunits: the pore-forming subunit, alpha, and a modulatory subunit, beta. Expression of the beta subunit induces dramatic changes in alpha subunit function. It increases the apparent Ca2+ sensitivity and it allows dehydrosoyasaponin I (DHS-I) to upregulate the channel. 2. The functional coupling of maxi KCa channel alpha and beta subunits in freshly dissociated human coronary smooth muscle cells was assessed. To distinguish maxi KCa currents modulated by the beta subunit, we examined (a) their apparent Ca2+ sensitivity, as judged from the voltage necessary to half-activate the channel (V1/2), and (b) their activation by DHS-I. 3. In patches with unitary currents, the majority of channels were half-activated near -85 mV at 18 microM Ca2+, a value similar to that obtained when the human KCa channel alpha (HSLO) and beta (HKV,Ca beta) subunits are co-expressed. A small number of channels half-activated around 0 mV, suggesting the activity of the alpha subunit alone. 4. The properties of macroscopic currents were consistent with the view that most pore-forming alpha subunits were coupled to beta subunits, since the majority of currents had values for V1/2 near to -90 mV, and currents were potentiated by DHS-I. 5. We conclude that in human coronary artery smooth muscle cells, most maxi KCa channels are composed of alpha and beta subunits. The higher Ca2+ sensitivity of maxi KCa channels, resulting from their coupling to beta subunits, suggests an important role of this channel in regulating coronary tone. Their massive activation by micromolar Ca2+ concentrations may lead to a large hyperpolarization causing profound changes in coronary blood flow and cardiac function.
authors.affiliation: Department of Anesthesiology, UCLA 90095-1778, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: P
authors.initials: P
authors.lastname: Meera
authors.forename: M
authors.initials: M
authors.lastname: Song
authors.forename: H G
authors.initials: HG
authors.lastname: Knaus
authors.forename: L
authors.initials: L
authors.lastname: Toro
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002648:Child; D003331:Coronary Vessels / Q000737:chemistry* / Q000502:physiology; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology; D051037:Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; D051038:Large-Conductance Calcium-Activated Potassium Channel beta Subunits; D051036:Large-Conductance Calcium-Activated Potassium Channels; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009131:Muscle, Smooth, Vascular / Q000737:chemistry* / Q000166:cytology / Q000187:drug effects; D009828:Oleanolic Acid / Q000031:analogs & derivatives*; D009865:Oocytes / Q000737:chemistry / Q000502:physiology; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000737:chemistry* / Q000502:physiology*; D024681:Potassium Channels, Calcium-Activated; D012503:Saponins / Q000494:pharmacology; D014315:Triterpenes / Q000494:pharmacology; D014982:Xenopus laevis
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D051037:Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; D051038:Large-Conductance Calcium-Activated Potassium Channel beta Subunits; D051036:Large-Conductance Calcium-Activated Potassium Channels; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D012503:Saponins; D014315:Triterpenes; C071764:dehydrosoyasaponin I; D009828:Oleanolic Acid; D002118:Calcium